The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory
Abstract
FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol hydrochloride) prolongs survival of solid organ allografts in animal models. Mechanisms of FTY720 immunomodulation were studied in mice infected with lymphocytic choriomeningitis virus (LCMV) to assess T cell responses or with vesicular stomatitis virus to evaluate Ab responses. Oral FTY720 (0.3 mg/kg/day) did not affect LCMV replication and specific CTL and B cells were induced and expanded normally. Moreover, the anti-viral humoral immune responses were normal. However, FTY720 treatment showed first a shift of overall distribution of CTL from the spleen to peripheral lymph nodes and lymphocytopenia was observed. This effect was reversible within 7–21 days. Together with unimpaired T and B cell memory after FTY720 treatment, this finding rendered enhancement of lymphocyte apoptosis by FTY720 in vivo unlikely. Secondly, the delayed-type hypersensitivity reaction to a viral MHC class I-presented peptide was markedly reduced by FTY720. These results were supported by impaired circulation of LCMV specific TCR transgenic effector lymphocytes in the peripheral blood and reduced numbers of tissue infiltrating CTL in response to delayed-type hypersensitivity reaction. Thirdly, in a CD8+ T cell-mediated diabetes model in a transgenic mouse expressing the LCMV glycoprotein in the islets of the pancreas, FTY720 delayed or prevented disease by reducing islet-infiltrating CTL. Thus, FTY720 effectively reduced recirculation of CD8+ effector T cells and their recruitment to peripheral lesions without affecting the induction and expansion of immune responses in secondary lymphoid organs. These properties may offer the potential to treat ongoing organ-specific T cell-mediated immunopathologic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zinkernagel, R. M., & Doherty, P. C. (1979) · Advances in Immunology · doi:10.1016/s0065-2776(08)60262-x · Cited by 1,933
Self-citationOates, J. A., Wood, A. J. J., & Kahan, B. D. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212507 · Cited by 1,359
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,173
Self-citationTherapy with monoclonal antibodies by elimination of T-cell subsets in vivo
Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D., & Waldmann, H. (1984) · Nature · doi:10.1038/312548a0 · Cited by 863
The Pharmacology and Clinical Use of Methotrexate
Jolivet, J., Cowan, K. H., Curt, G. A., Clendeninn, N. J., & Chabner, B. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311033091805 · Cited by 786
Massive Expansion of Antigen-Specific CD8+ T Cells during an Acute Virus Infection
Butz, E. A., & Bevan, M. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80469-0 · Cited by 769
Chiba, K., Yanagawa, Y., Masubuchi, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M., & Hoshino, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.5037 · Cited by 596
The Virology and Immunobiology of Lymphocytic Choriomeningitis Virus Infection
Buchmeier, M. J., Welsh, R. M., Dutko, F. J., & Oldstone, M. B. A. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60197-2 · Cited by 545
FUJITA, T., INOUE, K., YAMAMOTO, S., IKUMOTO, T., SASAKI, S., TOYAMA, R., CHIBA, K., HOSHINO, Y., & OKUMOTO, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.208 · Cited by 540
Battegay, M., Cooper, S., Althage, A., Bänziger, J., Hengartner, H., & Zinkernagel, R. M. (1991) · Journal of Virological Methods · doi:10.1016/0166-0934(91)90018-u · Cited by 475
Self-citationNEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
Self-citationThe half-lives of serum immunoglobulins in adult mice
Vieira, P., & Rajewsky, K. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180221 · Cited by 445
Lymphocytic Choriomeningitis Virus
(2016) · Molecular Detection of Human Viral Pathogens · doi:10.1201/b13590-72 · Cited by 402
The Biology of Lymphocytic Choriomeningitis Infection: Virus-induced Immune Disease
Hotchin, J. (1962) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1962.027.001.046 · Cited by 305
Borrow, P., Evans, C. F., & Oldstone, M. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1059-1070.1995 · Cited by 291
Suzuki, S., Enosawa, S., Kakefuda, T., Shinomiya, T., Amari, M., Naoe, S., Hoshino, Y., & Chiba, K. (1996) · Transplantation · doi:10.1097/00007890-199601270-00006 · Cited by 283
T-cell memory: the connection between function, phenotype and migration pathways
Mackay, C. R. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90051-t · Cited by 265
Yanagawa, Y., Sugahara, K., Kataoka, H., Kawaguchi, T., Masubuchi, Y., & Chiba, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5493 · Cited by 260
Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts.
Zimmerman, C., Brduscha-Riem, K., Blaser, C., Zinkernagel, R. M., & Pircher, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1367 · Cited by 250
Self-citationOehen, S., Waldner, H., Kündig, T. M., Hengartner, H., & Zinkernagel, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1273 · Cited by 201
Self-citationMYRIOCIN, A NEW ANTIFUNGAL ANTIBIOTIC FROM MYRIOCOCCUM ALBOMYCES
KLUEPFEL, D., BAGLI, J., BAKER, H., CHAREST, M.-P., KUDELSKI, A., SEHGAL, S. N., & VÉZINA, C. (1972) · The Journal of Antibiotics · doi:10.7164/antibiotics.25.109 · Cited by 201
Induction of long-lived germinal centers associated with persisting antigen after viral infection.
Bachmann, M. F., Odermatt, B., Hengartner, H., & Zinkernagel, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2259 · Cited by 194
Self-citationFTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
Brinkmann, V., Pinschewer, D., Chiba, K., & Feng, L. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01419-4 · Cited by 163
Self-citationBiologic Properties of Two Plaque Variants of Vesicular Stomatitis Virus (Indiana Serotype)
Wagner, R. R., Levy, A. H., Snyder, R. M., Ratcliff, G. A., & Hyatt, D. F. (1963) · The Journal of Immunology · doi:10.4049/jimmunol.91.1.112 · Cited by 152
Steinhoff, U., Müller, U., Schertler, A., Hengartner, H., Aguet, M., & Zinkernagel, R. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2153-2158.1995 · Cited by 126
Self-citationA new immunosuppressant, FTY720, induces bcl‐2‐associated apoptotic cell death in human lymphocytes
Suzuki, S., LI, X. ‐., Enosawa, S., & Shinomiya, T. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-777.x · Cited by 118
Kägi, D., Odermatt, B., Ohashi, P. S., Zinkernagel, R. M., & Hengartner, H. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2143 · Cited by 118
Self-citationYANAGAWA, Masubuchi, & Chiba (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00639.x · Cited by 115
Enosawa, S., Suzuki, S., Kakefuda, T., Li, X., & Amemiya, H. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00132-4 · Cited by 82
Oehen, S., Brduscha‐Riem, K., Oxenius, A., et al. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00089-6 · Cited by 64
Moskophidis, D., & Lehmann-Grube, F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3291 · Cited by 55
Roost, H., Charan, S., & Zinkernagel, R. M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201204 · Cited by 53
Self-citationSkin test to assess virus-specific cytotoxic T-cell activity.
Kündig, T. M., Althage, A., Hengartner, H., & Zinkernagel, R. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7757 · Cited by 42
Self-citationImmunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction
Bachmann, M. F., Hengartner, H., & Zinkernagel, R. M. (1994) · Medical Microbiology and Immunology · doi:10.1007/bf00196682 · Cited by 22
Self-citationLymphocytic Choriomeningitis Virus
Lehmann-Grube, F. (1971) · Springer eBooks · doi:10.1007/978-3-7091-8276-5_1 · Cited by 12
Cited by
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504
Self-citationHoming and cellular traffic in lymph nodes
von Andrian, U. H., & Mempel, T. R. (2003) · Nature Reviews Immunology · doi:10.1038/nri1222 · Cited by 1,281
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Self-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054
Metadata
- Authors
- Pinschewer, D. D., Ochsenbein, A. F., Odermatt, B., Brinkmann, V., Hengartner, H., & Zinkernagel, R. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06-01
- Volume
- 164
- Issue
- 11
- Pages
- 5761-5770
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1654241956
- Cited by
- 365
- References
- 35
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.